PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy

Overview of attention for article published in Clinical Epigenetics, September 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 11,242 followers.

PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer… https://t.co/Wf8cYu9Qhu

PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer https://t.co/ZEEjNf8Och

Epigenetics PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free ... https://t.co/zvxJS0QNL3 Sample Prep

PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in... https://t.co/2mAUxNgjo3 #epigenetics

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.